NCT07006883

Brief Summary

There is a notable and emerging use of structured exercise programs incorporating Yoga for chronic musculoskeletal pain. However, regarding knee osteoarthritis (KOA), the effectiveness of Yoga remains uncertain to justify its inclusion in therapeutic exercise programs in routine clinical practice. Therefore, the aim of this project is to evaluate the effects of Yoga on functionality in individuals with KOA. For this purpose, participants with KOA, including individuals of both sexes, aged 45 years or older, with a clinical diagnosis of KOA, will be randomly allocated using a random sequence generated by software, organized in six blocks of 24 codes, with an allocation ratio of 1:1, numbered sequentially from 1 to 126. Allocation will be concealed and performed after pre-intervention assessment and confirmation of eligibility criteria. Participants will be distributed into two groups: (1) Experimental group - Yoga (n = 45) and (2) Control group - therapeutic exercise (n = 45). The intervention will last 8 weeks, with assessments conducted at baseline, after 4 weeks, and after 8 weeks of the intervention programs. The following outcome measures will be used: Knee Injury and Osteoarthritis Outcome Score (KOOS), Berg Balance Scale (BBS), Numeric Pain Rating Scale (NPRS), Pain Self-Efficacy Questionnaire (PSEQ), Global Perceived Effect Scale (GPE), 30-Second Sit-to-Stand Test (30s-STS), Timed Up and Go Test (TUG), and Maximal Voluntary Isometric Contraction (MVIC). Data analysis will include a normality test to verify the distribution of the data, followed by the appropriate statistical tests for intra- and intergroup comparisons. The comparisons will consider two factors: time and group. A significance level of 5% (p \< 0.05) will be adopted for all analyses.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable knee-osteoarthritis

Timeline
34mo left

Started Aug 2025

Longer than P75 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Aug 2025Jan 2029

First Submitted

Initial submission to the registry

May 28, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 5, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2029

Last Updated

December 18, 2025

Status Verified

December 1, 2025

Enrollment Period

3.5 years

First QC Date

May 28, 2025

Last Update Submit

December 11, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Functional disability

    Knee Injury and Osteoarthritis Outcome Score (KOOS). It aims to evaluate the domains of pain, symptoms, activities of daily living, function related to recreation and sports, and quality of life related to the knee. Totaling 42 items, each item must be answered using a Likert scale that ranges from 0 (best score) to 4 (worst score), and the score for each subscale ranges from 0 (worst score) to 100 (best score).

    Change from Baseline, after 4 weeks of intervention and 8 weeks after the end of the intervention.

Secondary Outcomes (7)

  • Numerical Pain Scale

    Change from Baseline, after 4 weeks of intervention and 8 weeks after the end of the intervention.

  • Functional self-perception

    Change from Baseline, after 4 weeks of intervention and 8 weeks after the end of the intervention.

  • Global Perception of Change scale

    Change from Baseline, after 4 weeks of intervention and 8 weeks after the end of the intervention.

  • Dynamic balance

    Change from Baseline, after 4 weeks of intervention and 8 weeks after the end of the intervention.

  • Maximum voluntary isometric contraction

    Change from Baseline, after 4 weeks of intervention and 8 weeks after the end of the intervention.

  • +2 more secondary outcomes

Study Arms (2)

Therapeutic exercise group

ACTIVE COMPARATOR

The program consists of warm-up, strengthening, and mobility exercises, based on functional movements that are typically challenging for individuals with knee osteoarthritis (KOA), in addition to balance exercises previously defined in a prior clinical trial. The program will be delivered in three phases: Phase 1 (weeks 0-2), Phase 2 (weeks 2-4), and Phase 3 (weeks 4-8). Every two weeks, participants will be reassessed to allow for potential adjustments aimed at promoting the progressive progression of the exercises.

Other: Therapeutic exercise

Yoga therapeutic exercise

EXPERIMENTAL

The program was developed based on previous studies and considering the functional demands of each established position, as detailed in Tables 4, 5, and 6. The intervention will be structured into three phases: Phase 1 (weeks 0-2), Phase 2 (weeks 2-4), and Phase 3 (weeks 4-8). Every two weeks, participants will be reassessed to allow for potential adjustments, aiming to ensure the progressive progression of the exercises.

Other: Yoga therapeutic exercise

Interventions

Therapeutic exercise focused on muscle strengthening, balance, and functional performance.

Therapeutic exercise group

Yoga is a mind-body practice that integrates physical postures, breathing techniques, and mindfulness with the aim of improving physical function, balance, strength, mobility, and psychological well-being. I

Yoga therapeutic exercise

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A clinical diagnosis of knee osteoarthritis (knee pain for \> 3 months)
  • Morning stiffness \<30 minutes
  • Crepitus
  • Bone tenderness, and absence of palpable heat and/or diagnosis established radiographically (determined by Kellgren and Lawrence grade 1 to 3 on a scale 1 up to 4)

You may not qualify if:

  • Bilateral hip or KOA
  • Severe osteoporosis
  • Fibromyalgia
  • Clinical history of tumors or cancer
  • Active inflammatory joint diseases (rheumatoid arthritis, gout), undergoing any joint replacement of the lower extremity
  • Neurological diseases (Parkinson's disease, Stroke, Multiple Sclerosis, muscular dystrophies, neuromotor disease, Alzheimer's disease)
  • Infected wounds or osteomyelitis in the knee region
  • Deep vein thrombosis or thrombophlebitis, sensory changes in the lower limbs
  • A cognitive and cardiopulmonary impairment that may prevent or limit the performance of exercises
  • Use of a walking assistance device, history of recent trauma to the knee
  • Be performing or having prior any form of treatment involving physiotherapy, intra-articular corticosteroids, anti-inflammatories, opioid medication, or chondroprotective in the six months before the start of interventions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Nove de Julho

São Paulo, 01504-001, Brazil

RECRUITING

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Exercise Therapy

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Phd

Study Record Dates

First Submitted

May 28, 2025

First Posted

June 5, 2025

Study Start

August 1, 2025

Primary Completion (Estimated)

January 30, 2029

Study Completion (Estimated)

January 30, 2029

Last Updated

December 18, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations